PMID: 8956327Nov 1, 1996Paper

Development of Caco-2 cells expressing high levels of cDNA-derived cytochrome P4503A4

Pharmaceutical Research
C L CrespiM Hu

Abstract

To develop Caco-2 cell derivatives expressing high levels of human cytochrome P450 drug metabolizing enzymes. The cDNAs for two cytochrome P450 forms, CYP2A6 and CYP3A4, were introduced into an extrachromosomal vector under control of the cytomegalovirus early intermediate promoter. Vector-bearing cells were selected via resistance to hygromycin B. Transfected cells exhibited high levels of cDNA-derived protein as measured by Western blot, spectrophotometric P450 determination and/or cytochrome P450 form-selective enzyme assay. CYP3A4 and CYP2A6 catalytic activities were about 100 fold higher than in control cells. cDNA-expressing cells were found to form tight monolayers and were suitable for study of xenobiotic transport and metabolism. The permeabilities of cephalexin, phenylalanine, mannitol and propranolol across transfected monolayers were found to be similar to those across untransfected monolayers. The appropriate transfected monolayers metabolized the CYP2A6 substrate coumarin and the CYP3A4 substrates testosterone and nifedipine. A Caco-2 cell system to simultaneously study drug transport and metabolism has been developed.

Citations

Jan 20, 1998·Drug and Chemical Toxicology·M M Doherty, K S Pang
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R E White
Nov 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·K Sandy Pang
May 23, 1998·Annual Review of Pharmacology and Toxicology·K E Thummel, G R Wilkinson
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marc VermeirGeert Mannens
Sep 5, 2006·Pharmaceutical Research·Timo KorjamoPaavo Honkakoski
Nov 11, 2009·Environmental and Molecular Mutagenesis·Emmanuelle BazinValérie Fessard
May 20, 1999·Annual Review of Pharmacology and Toxicology·F P Guengerich
Jun 18, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vikram AroraPatrick L Iversen
Feb 28, 2002·The Journal of Pharmacology and Experimental Therapeutics·Carolyn L CumminsLeslie Z Benet
May 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Saeed AlqahtaniAmal Kaddoumi
Sep 25, 2001·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S A Roberts
Jul 26, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Long HouKoichi Takahashi
Mar 7, 2009·Chemical Reviews·Stefan Balaz
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A BraunH Wunderli-Allenspach
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·A NakayamaB J Aungst
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C L CrespiD T Steimel
Aug 23, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Timo KorjamoJukka Mönkkönen
Apr 30, 2019·ACS Applied Materials & Interfaces·Md Saiful IslamOmathanu Perumal
Jan 29, 2011·Bioorganic & Medicinal Chemistry·Cécile D CrosJoanne T Blanchfield

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved